The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Jun. 05, 2012
Applicants:

Harish C. Joshi, Decatur, GA (US);

Ritu Aneja, Lilburn, GA (US);

Surya N. Vangapandu, Smyrna, GA (US);

Inventors:

Harish C. Joshi, Decatur, GA (US);

Ritu Aneja, Lilburn, GA (US);

Surya N. Vangapandu, Smyrna, GA (US);

Assignee:

Emory University, Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/42 (2006.01); C07D 491/00 (2006.01); A61K 31/4741 (2006.01); C07D 491/056 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4741 (2013.01); C07D 491/056 (2013.01); A61K 45/06 (2013.01);
Abstract

Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are noscapine analogs. The compounds and compositions can be used to treat and/or prevent a wide variety of cancers, including drug resistant cancers. While the antitussive plant alkaloid, noscapine, binds tubulin, displays anticancer activity, and has a safe pharmacological profile in humans, structure-function analyzes pointed to a proton at position 9 of the isoquinoline ring that can be modified without compromising tubulin binding activity. Noscapine analogs with various functional moieties at position 9 on the isoquinoline ring kill human cancer cells resistant to other anti-microtubule agents, such as vincas and taxanes.


Find Patent Forward Citations

Loading…